This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Heritage Insurance Margin Improves: Can It Retain the Momentum?
by Tanuka De
HRTG's net margin keeps rising as it leans into tech, E&S expansion and disciplined underwriting.
5 Mid & Small-Cap Stock Picks From the Booming P&C Insurance Industry
by Nalak Das
HRTG, HGTY, HCI, PLMR and UFCS shine as mid- and small-cap P&C insurers gain from pricing power and underwriting strength.
4 Insurance Stocks That Have Outperformed the S&P 500 in a Year
by Sushmita Sarker
Insurance Stocks HCI, HRTG, HMN and TRV outperform the industry, the sector and the S&P 500 composite, and look poised to retain the rally.
Skyward Specialty Insurance Group, Inc. (SKWD) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Hartford Partners With Nayya to Streamline Benefits Experience
by Zacks Equity Research
HIG joins forces with Nayya to provide tailored benefits suited to the individual needs of employees.
3 Reasons Why Growth Investors Shouldn't Overlook HCI Group (HCI)
by Zacks Equity Research
HCI Group (HCI) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Bulls Look Optimistic About HCI Group (HCI): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for HCI Group (HCI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks Investment Ideas feature highlights: UnitedHealth, Progressive and HCI
by Zacks Equity Research
UnitedHealth, Progressive and HCI are part of the Zacks Investment Ideas article.
After 30% Slide, is UNH Stock a Buy? Use the 3-Day Rule to Decide
by Ethan Feller
UnitedHealth Group stock has been rocked following a criminal investigation into the company. Is it time to buy shares?
Is HCI Group (HCI) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
HCI Group (HCI) could produce exceptional returns because of its solid growth attributes.
All You Need to Know About HCI Group (HCI) Rating Upgrade to Buy
by Zacks Equity Research
HCI Group (HCI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
HCI Group, Inc. (HCI) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
HCI Group (HCI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should Heritage Insurance Stock Be in Your Portfolio Post Q1 Earnings?
by Tanuka De
HRTG's growing commercial residential business, expanding E&S business and improving pricing to deliver better margins and boost earnings bode well for growth.
Compared to Estimates, HCI Group (HCI) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for HCI Group (HCI) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCI Group (HCI) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HCI Group (HCI) delivered earnings and revenue surprises of 19.15% and 2.98%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Root, Inc. (ROOT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Root (ROOT) delivered earnings and revenue surprises of 137.78% and 14.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Unveiling HCI Group (HCI) Q1 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for HCI Group (HCI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Wall Street Analysts Think HCI Group (HCI) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), HCI Group (HCI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
HCI Group, Inc. (HCI) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
HCI Group (HCI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
HCI Group (HCI) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
HCI Group (HCI) closed at $145.83 in the latest trading session, marking a +1.65% move from the prior day.
Hartford Financial Q1 Earnings Beat on Employee Benefits Strength
by Zacks Equity Research
HIG returns $550 million to shareholders in the first quarter via share buybacks and dividends.
Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI
by Zacks Equity Research
Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI are part of the Zacks Screen of the Week article.
HCI Group (HCI) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
HCI Group (HCI) closed the most recent trading day at $142.33, moving -1.6% from the previous trading session.
RenaissanceRe (RNR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of -365.63% and 7.79%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks With Recent Price Strength Amid Tariff-Led Volatility
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are HRTG, MRX, KINS, ANIP, HCI.